Help Patients With Skyrocketing Insulin Costs
One in four patients with diabetes will ration or even stop their insulin due to skyrocketing costs...sometimes leading to death.
In the U.S., only 3 companies make insulin...driving up prices.
You'll see more efforts to address costs...such as co-pay caps from some payers and states. And FDA is exploring ways to promote competition.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote